Mounjaro vs Wegovy: The Key Differences Explained

When you’re weighing up Mounjaro vs Wegovy: The Key Differences Explained, you’re looking at two of the most talked-about weight loss injections in the UK right now. Both medications fall into the growing category of GLP-1 receptor agonists, designed to help you shed pounds by curbing appetite, slowing gastric emptying and improving blood sugar control. Yet despite these similarities, important distinctions in efficacy, dosing schedules, cost and side effects can make one option feel like a better fit for your lifestyle and goals. In this guide you’ll find everything you need—from how each drug works to real-world results—to help you decide which injection could work best for you.

If you’re new to this class of therapies, you may also want to explore how the rise of weight loss injections in the UK has shaped access and awareness. And once you’ve narrowed your choice, our linked articles on understanding the Mounjaro KwikPen: a user guide or side effects of Wegovy and how to manage them will walk you through the finer details.

Understand Each Medication

Before comparing outcomes and costs, it helps to know what sits behind each brand name. Mounjaro and Wegovy share some features but differ in core ingredients and approvals.

What Is Mounjaro?

Mounjaro is the trade name for tirzepatide, a dual-action peptide that targets two hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). By engaging both receptors, Mounjaro can amplify feelings of fullness and improve insulin response. Initially approved for type 2 diabetes management, it earned a UK OK for weight loss in adults with obesity or overweight plus at least one weight-related condition.

What Is Wegovy?

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural GLP-1 hormone. This encourages satiety, reduces hunger-driven snacking and supports better blood sugar control. First authorised specifically for weight management, Wegovy has become a leading choice for those who need to lose 5 percent or more of their body weight.

Mechanism Of Action

While both drugs slow gastric emptying and reduce appetite, Mounjaro’s dual GIP/GLP-1 action may deliver a slightly different metabolic response than Wegovy’s GLP-1-only profile. Some research suggests tirzepatide users experience faster weight loss, especially during the initial titration phase. However, individual results vary based on dosage, diet, exercise and metabolic factors.

Key Characteristics At A Glance

Attribute	Mounjaro (Tirzepatide)	Wegovy (Semaglutide)
Active Ingredient	Tirzepatide	Semaglutide
Hormone Targets	GIP + GLP-1	GLP-1
Typical Weekly Dose Range	2.5 mg to 15 mg	0.25 mg to 2.4 mg
Injection Frequency	Once weekly	Once weekly
Average 6-Month Weight Loss	Up to 15 percent of body weight¹	Up to 10 percent of body weight²
UK Approval (Weight Loss)	2024	2022

¹ Source: SELECT trial, 2023
² Source: STEP trials, 2022

Compare Weight Loss Results

You naturally want to know which option will help you lose more weight, in what timeframe and with what consistency.

Clinical Trial Outcomes

In head-to-head studies, tirzepatide often edges out semaglutide on average weight reduction. In the SURPASS-2 trial, participants taking 15 mg of Mounjaro lost an average of 13 percent of their body weight over 40 weeks, while those on 1 mg semaglutide lost about 10 percent in the STEP 2 study. Even at lower doses, many Mounjaro users report steeper early declines on the scale.

Yet semaglutide trials show strong cardiovascular benefits and sustained weight maintenance. If you prioritise long-term health markers alongside weight loss, Wegovy’s solid track record—backed by large-scale STEP research—may appeal.

Real-World Effectiveness

Clinical figures don’t always translate fully outside trial settings. In everyday UK practice, your diet, exercise habits and support system play a pivotal role. Some clinics report similar real-world results for both drugs, with average losses of 8 to 12 percent after six months when combined with lifestyle coaching.

The key takeaway is that whichever injection you choose, a structured plan—regular check-ins, nutritional guidance and an exercise regimen—maximises your odds of success.

Review Dosage Schedules

Dosing strategies can influence how quickly you ramp up, how many injections you administer and how manageable your routine feels.

Mounjaro Dosing

You’ll start Mounjaro at 2.5 mg once weekly, usually on the same day each week. Every four weeks you can escalate the dose (5 mg, 7.5 mg, 10 mg, 12.5 mg and up to 15 mg) until you reach the dose that delivers optimal weight loss with tolerable side effects. Some people stay on 10 mg, while others find 15 mg more effective.

Wegovy Dosing

Wegovy titration is more gradual. You begin at 0.25 mg weekly and step up every four weeks through 0.5 mg, 1 mg, 1.7 mg and eventually 2.4 mg. This cautious approach helps your body acclimatise to gastrointestinal changes. Once you hit 2.4 mg, that becomes your maintenance dose for as long as needed.

Evaluate Side Effects

No medication is without trade-offs. Understanding side-effect profiles helps you plan for discomfort and decide how much you can tolerate.

Common Reactions

Both Mounjaro and Wegovy share gastrointestinal complaints: nausea, diarrhoea, constipation and occasional vomiting. You might also experience mild headache, fatigue or injection-site irritation. With Wegovy’s slower titration, some users report fewer early-stage symptoms, while Mounjaro’s dual-hormone activity can heighten GI effects during dose increases.

Managing Side Effects

To keep side effects at bay, start with small sips of water, eat slowly and favour low-fat, low-fibre meals in the first few weeks. Ginger tea can settle nausea, and over-the-counter remedies like loperamide help with diarrhoea. For a deeper dive, check out our guide on side effects of Wegovy and how to manage them.

Consider Cost And Access

Price and availability often determine which therapy you choose, especially in a private-pay environment.

Pricing In The UK

• Mounjaro
  Retail costs typically range from £200 to £300 per four-week supply, depending on dosage strength.
• Wegovy
  A monthly supply can cost between £250 and £350 at full private-pay rates.

Prices fluctuate with imports, currency shifts and pharmacy markups. Always request an upfront quote from your clinic or pharmacy.

NHS And Private Prescriptions

Currently neither Mounjaro nor Wegovy is routinely prescribed on the NHS for weight loss alone. Some NHS trusts run pilot programmes, but coverage is limited and often focused on patients with type 2 diabetes or severe obesity. Most people access these injections via private clinics, medical spas or online telehealth providers.

Injection Shortages

Global demand has occasionally outpaced supply, leading to intermittent shortages. Before committing, read our advice on weight loss injection shortages in the UK: what you need to know to learn strategies for securing a reliable supply.

Assess Patient Experience

Choosing an injection isn’t just about the molecule—it’s about how you’ll live with it week after week.

Administration Methods

Both medications come in pre-filled disposable pens. You administer a subcutaneous shot—usually in the abdomen, thigh or upper arm—on the same day each week at any time that suits you. Rotating sites prevents irritation.

Pen Devices

Mounjaro’s KwikPen delivers doses from 2.5 mg up to 15 mg in one device. If you need multiple pen strengths, you may use two pens in a week when stepping between doses. Learn more about handling and storing this pen in our understanding the Mounjaro KwikPen: a user guide.

Wegovy pens come in single-dose increments that match each titration stage, so you swap pens as you advance. The simplicity of one dose per pen means fewer dosing errors.

Choose Your Ideal Option

By now you’ve seen how Mounjaro vs Wegovy: The Key Differences Explained can steer you toward the best fit for your weight-loss journey. Here are some final pointers:

Suitability Considerations

• If you prioritise faster initial weight loss and can handle a steeper titration, Mounjaro might suit you better.
• If you prefer a gradual ramp-up and emphasise cardiovascular benefits shown in large-scale trials, Wegovy could be your pick.
• For mild side effects and a cautious introduction, Wegovy’s five-step dosing may feel gentler.
• If you don’t mind juggling pen strengths for a potential efficacy boost, Mounjaro’s dual action could pay dividends.

Tips For Starting

• Synchronise your injection day with a routine task—like Monday morning breakfast—to build consistency.
• Keep a small diary or app reminder for dose escalations and appointment check-ins.
• Pair your injection plan with a balanced diet rich in vegetables, protein and whole grains, plus 150 minutes of moderate exercise weekly.
• Stay in touch with your prescribing clinic, especially during the first 8 weeks when most dose changes and side-effect troubleshooting occur.

• Celebrate each milestone, whether it’s a 5 percent weight loss or two weeks of nausea-free mornings.
• Reach out to support groups or online communities—you’ll find plenty of people sharing tips on everything from meal planning to mindset shifts.

Final Thoughts

Selecting between Mounjaro and Wegovy comes down to your personal goals, how your body responds and practical factors like cost and supply. By understanding mechanism, trial data, dosing and side effects, you’re now equipped to make an informed choice. Remember that medication is one piece of the puzzle—pairing it with a healthy lifestyle and professional guidance will help you achieve lasting success. Good luck on your journey to a healthier you!